Skip to main content
Top
Published in: BMC Primary Care 1/2012

Open Access 01-12-2012 | Research article

What differentiates primary care physicians who predominantly prescribe diuretics for treating mild to moderate hypertension from those who do not? A comparative qualitative study

Authors: Christian M Rochefort, Julia Morlec, Robyn M Tamblyn

Published in: BMC Primary Care | Issue 1/2012

Login to get access

Abstract

Background

Thiazide diuretics are cost-effective for the treatment of mild to moderate hypertension, but physicians often opt for more expensive treatment options such as angiotensin II receptor blockers or angiotensin converting enzyme inhibitors. With escalating health care costs, there is a need to elucidate the factors influencing physicians' treatment choices for this highly prevalent chronic condition. The purpose of this study was to describe the characteristics of physicians' decision-making process regarding hypertension treatment choices.

Methods

A comparative qualitative study was conducted in 2009 in the Canadian province of Quebec. Overall, 29 primary care physicians--who are also participating in an electronic health record research program--participated in a semi-structured interview about their prescribing decisions. Physicians were categorized into two groups based on their patterns of prescribing antihypertensive drugs: physicians who predominantly prescribe diuretics, and physicians who predominantly prescribe drug classes other than diuretics. Cases of hypertension that were newly started on antihypertensive therapy were purposely selected from each physician's electronic health record database. Chart stimulated recall interview, a technique utilizing patient charts to probe recall and provide context to physician decision-making during clinical encounters, was used to elucidate reasons for treatment choices. Interview transcripts were synthesized using content analysis techniques, and factors influencing physicians' decision making were inductively generated from the data.

Results

We identified three themes that differentiated physicians who predominantly prescribe diuretics from those who predominantly prescribe other drug classes for the initial treatment of mild to moderate hypertension: a) perceptions about the efficacy of diuretics, b) preferred approach to hypertension management and, c) perceptions about hypertension guidelines. Specifically, physicians had differences in beliefs about the efficacy, safety and tolerability of diuretics, the most effective approach for managing mild to moderate hypertension, and in aggressiveness to achieve treatment targets. Marketing strategies employed by the pharmaceutical industry and practice experience appear to contribute to these differences in management approach.

Conclusions

Physicians preferring more expensive treatment options appear to have several misperceptions about the efficacy, safety and tolerability of diuretics. Efforts to increase physicians' prescribing of diuretics may need to be directed at overcoming these misperceptions.
Literature
1.
go back to reference Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense H-W, Joffres M, Kastarinen M, Poulter N, Primatesta P, Rodríguez-Altalejo F, Stegmayr B, Thamm M, Tuomilehto J, Vannuzzo D, Vescio F: Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA. 2003, 289 (18): 2363-2369. 10.1001/jama.289.18.2363.CrossRefPubMed Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense H-W, Joffres M, Kastarinen M, Poulter N, Primatesta P, Rodríguez-Altalejo F, Stegmayr B, Thamm M, Tuomilehto J, Vannuzzo D, Vescio F: Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA. 2003, 289 (18): 2363-2369. 10.1001/jama.289.18.2363.CrossRefPubMed
2.
go back to reference Hajjar I, Kotchen JM, Kotchen TA: Hypertension: trends in prevalence, incidence and control. Annu Rev Public Health. 2006, 27: 465-490. 10.1146/annurev.publhealth.27.021405.102132.CrossRefPubMed Hajjar I, Kotchen JM, Kotchen TA: Hypertension: trends in prevalence, incidence and control. Annu Rev Public Health. 2006, 27: 465-490. 10.1146/annurev.publhealth.27.021405.102132.CrossRefPubMed
3.
go back to reference Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ: Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension. 2008, 52: 818-827. 10.1161/HYPERTENSIONAHA.108.113357.CrossRefPubMed Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ: Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension. 2008, 52: 818-827. 10.1161/HYPERTENSIONAHA.108.113357.CrossRefPubMed
4.
go back to reference Kannel WB: Blood pressure as a cardiac risk factor: prevention and treatment. JAMA. 1996, 275 (4): 1571-1576.CrossRefPubMed Kannel WB: Blood pressure as a cardiac risk factor: prevention and treatment. JAMA. 1996, 275 (4): 1571-1576.CrossRefPubMed
5.
go back to reference Yusuf S, Hawken S, Ôunpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L, On behalf of the INTERHEART Study investigators: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART Study): case-control study. Lancet. 2004, 364: 937-952. 10.1016/S0140-6736(04)17018-9.CrossRefPubMed Yusuf S, Hawken S, Ôunpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L, On behalf of the INTERHEART Study investigators: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART Study): case-control study. Lancet. 2004, 364: 937-952. 10.1016/S0140-6736(04)17018-9.CrossRefPubMed
6.
go back to reference Hemmelgarn BR, Chen G, Walker R, McAlister FA, Quan H, Tu K, Khan N, Campbell N: Trends in antihypertensive drug prescriptions and physician visits in Canada between 1996 and 2006. Can J Cardiol. 2008, 24 (6): 507-512. 10.1016/S0828-282X(08)70627-5.CrossRefPubMedPubMedCentral Hemmelgarn BR, Chen G, Walker R, McAlister FA, Quan H, Tu K, Khan N, Campbell N: Trends in antihypertensive drug prescriptions and physician visits in Canada between 1996 and 2006. Can J Cardiol. 2008, 24 (6): 507-512. 10.1016/S0828-282X(08)70627-5.CrossRefPubMedPubMedCentral
7.
go back to reference Klarenbach SW, McAlister FA, Johansen H, Tu K, Hazel MA, Walker R, Zarnke KB, Campbell NRC, For the Canadian Hypertension Education Program: Identification of factors driving differences in cost effectiveness of first-line pharmacological therapy for uncomplicated hypertension. Can J Cardiol. 2010, 26 (5): e158-e163. 10.1016/S0828-282X(10)70383-4.CrossRefPubMedPubMedCentral Klarenbach SW, McAlister FA, Johansen H, Tu K, Hazel MA, Walker R, Zarnke KB, Campbell NRC, For the Canadian Hypertension Education Program: Identification of factors driving differences in cost effectiveness of first-line pharmacological therapy for uncomplicated hypertension. Can J Cardiol. 2010, 26 (5): e158-e163. 10.1016/S0828-282X(10)70383-4.CrossRefPubMedPubMedCentral
8.
go back to reference Hackam DG, Khan NA, Hemmelgarn BR, Rakin SW, Touyz RM, Campbell NRC, Padwal R, Campbell TS, Lindsay PM, Hill MD, Quinn RR, Mahon JL, Herman RJ, Shiffrin EL, Ruzicka M, Larochelle P, Feldman RD, Lebel M, Poirier L, Arnold JMO, Moe GW, Howlett JG, Trudeau L, Bacon SL, Petrella RJ, Milot A, Stone JA, Drouin D, Boulanger JM, Sharma M, Hamet P, Fodor G, Dresser GK, Carruthers SG, Pylypchuk G, Burgess ED, Burns KD, Vallée M, Prasad Hamet P, Fodor G, Dresser GK, Carruthers SG, Pylypchuk G, Burgess ED, Burns KD, Vallée M, Prasad GV, Gilbert RE, Leiter LA, Jones C, Ogilvie RI, Woo V, McFarlane PA, Hegele RA, Tobe SW, Canadian Hypertension Education Program: The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2--therapy. Can J Cardiol. 2010, 26 (5): 249-258. 10.1016/S0828-282X(10)70379-2.CrossRefPubMedPubMedCentral Hackam DG, Khan NA, Hemmelgarn BR, Rakin SW, Touyz RM, Campbell NRC, Padwal R, Campbell TS, Lindsay PM, Hill MD, Quinn RR, Mahon JL, Herman RJ, Shiffrin EL, Ruzicka M, Larochelle P, Feldman RD, Lebel M, Poirier L, Arnold JMO, Moe GW, Howlett JG, Trudeau L, Bacon SL, Petrella RJ, Milot A, Stone JA, Drouin D, Boulanger JM, Sharma M, Hamet P, Fodor G, Dresser GK, Carruthers SG, Pylypchuk G, Burgess ED, Burns KD, Vallée M, Prasad Hamet P, Fodor G, Dresser GK, Carruthers SG, Pylypchuk G, Burgess ED, Burns KD, Vallée M, Prasad GV, Gilbert RE, Leiter LA, Jones C, Ogilvie RI, Woo V, McFarlane PA, Hegele RA, Tobe SW, Canadian Hypertension Education Program: The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2--therapy. Can J Cardiol. 2010, 26 (5): 249-258. 10.1016/S0828-282X(10)70379-2.CrossRefPubMedPubMedCentral
9.
go back to reference Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ, National High Blood Pressure Education Program Coordinating Committee: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 Report. JAMA. 2003, 289: 2560-2572. 10.1001/jama.289.19.2560.CrossRefPubMed Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ, National High Blood Pressure Education Program Coordinating Committee: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 Report. JAMA. 2003, 289: 2560-2572. 10.1001/jama.289.19.2560.CrossRefPubMed
10.
go back to reference The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group: Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic: the Antihypertensive and Lipid Lowering Treatment to prevent Heart Attack Trial (ALLHAT). JAMA. 2002, 288: 2977-2981. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group: Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic: the Antihypertensive and Lipid Lowering Treatment to prevent Heart Attack Trial (ALLHAT). JAMA. 2002, 288: 2977-2981.
11.
go back to reference Wing LMH, Reid CM, Ryan P, Beilin LJ, Brown MA, Jennings GLR, Johnston CI, McNeil JJ, MacDonald GJ, Marley JE, Morgan TO, West MJ, For the Second Australian National Blood Pressure Study Group: A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in elderly. N Engl J Med. 2003, 348 (7): 583-592. 10.1056/NEJMoa021716.CrossRefPubMed Wing LMH, Reid CM, Ryan P, Beilin LJ, Brown MA, Jennings GLR, Johnston CI, McNeil JJ, MacDonald GJ, Marley JE, Morgan TO, West MJ, For the Second Australian National Blood Pressure Study Group: A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in elderly. N Engl J Med. 2003, 348 (7): 583-592. 10.1056/NEJMoa021716.CrossRefPubMed
12.
go back to reference Psaty BM, Lumley T, Furberg CD, Schellenbaum G, Pahor M, Alderman MH, Weiss NS: Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA. 2003, 289: 2534-2544. 10.1001/jama.289.19.2534.CrossRefPubMed Psaty BM, Lumley T, Furberg CD, Schellenbaum G, Pahor M, Alderman MH, Weiss NS: Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA. 2003, 289: 2534-2544. 10.1001/jama.289.19.2534.CrossRefPubMed
13.
go back to reference Staessen JA, Wang JG, Thijs L: Cardiovascular prevention and blood pressure reduction: A quantitative overview updated until 1 March 2003. J Hypertens. 2003, 21 (6): 1055-1076. 10.1097/00004872-200306000-00002.CrossRefPubMed Staessen JA, Wang JG, Thijs L: Cardiovascular prevention and blood pressure reduction: A quantitative overview updated until 1 March 2003. J Hypertens. 2003, 21 (6): 1055-1076. 10.1097/00004872-200306000-00002.CrossRefPubMed
14.
go back to reference Staessen JA, Li Y, Thijs L, Wang JG: Blood pressure reduction and cardiovascular prevention: an update including the 2003-2004 secondary prevention trials. Hypertens Res. 2005, 28 (5): 385-407. 10.1291/hypres.28.385.CrossRefPubMed Staessen JA, Li Y, Thijs L, Wang JG: Blood pressure reduction and cardiovascular prevention: an update including the 2003-2004 secondary prevention trials. Hypertens Res. 2005, 28 (5): 385-407. 10.1291/hypres.28.385.CrossRefPubMed
15.
go back to reference Lindholm LH, Carlberg B, Samuelsson O: Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis. Lancet. 2005, 366: 1545-1553. 10.1016/S0140-6736(05)67573-3.CrossRefPubMed Lindholm LH, Carlberg B, Samuelsson O: Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis. Lancet. 2005, 366: 1545-1553. 10.1016/S0140-6736(05)67573-3.CrossRefPubMed
16.
go back to reference Law MR, Morris JK, Wald NJ: Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009, 338: 1-19. 10.1136/bmj.b1.CrossRef Law MR, Morris JK, Wald NJ: Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009, 338: 1-19. 10.1136/bmj.b1.CrossRef
17.
go back to reference National Collaborating Centre for Chronic Conditions: Management of hypertension in adults in primary care. NICE Clinical Guidelines 18. 2006, London: Royal College of Physicians National Collaborating Centre for Chronic Conditions: Management of hypertension in adults in primary care. NICE Clinical Guidelines 18. 2006, London: Royal College of Physicians
18.
go back to reference Whitworth JA: 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003, 21 (11): 1983-1992.CrossRefPubMed Whitworth JA: 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003, 21 (11): 1983-1992.CrossRefPubMed
19.
go back to reference Guertin JR, Jackevicius CA, Cox JL, Humphries K, Pilote L, So DY, Tu JV, Wijeysundera H, Rinfret S, For the Canadian Cardiovascular Outcomes Research Team: The potential economic impact of restricted access to angiotensin-receptor blockers. CMAJ. 2011, 18 (3): E180-E186.CrossRef Guertin JR, Jackevicius CA, Cox JL, Humphries K, Pilote L, So DY, Tu JV, Wijeysundera H, Rinfret S, For the Canadian Cardiovascular Outcomes Research Team: The potential economic impact of restricted access to angiotensin-receptor blockers. CMAJ. 2011, 18 (3): E180-E186.CrossRef
20.
go back to reference Simon SR, Rodriguez HP, Majumdar SR, Kleinman K, Warner C, Salem-Schatz S, Miroshnik I, Soumerai SB, Prosser LA: Economic analysis of a randomized trial of academic detailing interventions to improve use of antihypertensive medications. J Clin Hypertens. 2007, 9 (1): 15-20. 10.1111/j.1524-6175.2006.05684.x.CrossRef Simon SR, Rodriguez HP, Majumdar SR, Kleinman K, Warner C, Salem-Schatz S, Miroshnik I, Soumerai SB, Prosser LA: Economic analysis of a randomized trial of academic detailing interventions to improve use of antihypertensive medications. J Clin Hypertens. 2007, 9 (1): 15-20. 10.1111/j.1524-6175.2006.05684.x.CrossRef
21.
go back to reference Hill MN, Miller NH, DeGeest S, On Behalf of the American Society of Hypertension Writing Group: ASH Position Paper: adherence and persistence with taking medication to control high blood pressure. J Clin Hypertens. 2010, 12 (10): 757-764. 10.1111/j.1751-7176.2010.00356.x.CrossRef Hill MN, Miller NH, DeGeest S, On Behalf of the American Society of Hypertension Writing Group: ASH Position Paper: adherence and persistence with taking medication to control high blood pressure. J Clin Hypertens. 2010, 12 (10): 757-764. 10.1111/j.1751-7176.2010.00356.x.CrossRef
22.
go back to reference Grégoire JP, Moisan J, Guibert R, Ciampi A, Milot A, Gaudet M, Côté I: Determinants of discontinuation of new courses of antihypertensive medications. J Clin Epidemiol. 2002, 55 (7): 728-735. 10.1016/S0895-4356(02)00400-6.CrossRefPubMed Grégoire JP, Moisan J, Guibert R, Ciampi A, Milot A, Gaudet M, Côté I: Determinants of discontinuation of new courses of antihypertensive medications. J Clin Epidemiol. 2002, 55 (7): 728-735. 10.1016/S0895-4356(02)00400-6.CrossRefPubMed
23.
go back to reference Tamblyn R, Lavoie G, Petrella L, Monette J: The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Quebec. J Clin Epidemiol. 1995, 48 (8): 999-1009. 10.1016/0895-4356(94)00234-H.CrossRefPubMed Tamblyn R, Lavoie G, Petrella L, Monette J: The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Quebec. J Clin Epidemiol. 1995, 48 (8): 999-1009. 10.1016/0895-4356(94)00234-H.CrossRefPubMed
24.
go back to reference Tamblyn R, Abrahamowicz M, Dauphinee D, Wenghofer E, Jacques A, Klass D, Smee S, Eguale T, Winslade N, Girard N, Bartman I, Buckeridge DL, Hanley JA: Influence of physicians' management and communication ability on patients' persistence with antihypertensive medication. Arch Intern Med. 2010, 170 (12): 1064-1072. 10.1001/archinternmed.2010.167.CrossRefPubMed Tamblyn R, Abrahamowicz M, Dauphinee D, Wenghofer E, Jacques A, Klass D, Smee S, Eguale T, Winslade N, Girard N, Bartman I, Buckeridge DL, Hanley JA: Influence of physicians' management and communication ability on patients' persistence with antihypertensive medication. Arch Intern Med. 2010, 170 (12): 1064-1072. 10.1001/archinternmed.2010.167.CrossRefPubMed
25.
go back to reference Cadieux G, Abrahamowicz M, Dauphinee D, Tamblyn R: Are physicians with better clinical skills on licensing examinations less likely to prescribe antibiotics for viral respiratory infections in ambulatory care settings?. Med Care. 2011, 49 (2): 156-165. 10.1097/MLR.0b013e3182028c1a.CrossRefPubMed Cadieux G, Abrahamowicz M, Dauphinee D, Tamblyn R: Are physicians with better clinical skills on licensing examinations less likely to prescribe antibiotics for viral respiratory infections in ambulatory care settings?. Med Care. 2011, 49 (2): 156-165. 10.1097/MLR.0b013e3182028c1a.CrossRefPubMed
26.
go back to reference Tamblyn R, Huang A, Perreault R, Jacques A, Roy D, Hanley J, McLeod P, Laprise R: The Medical Office of the 21st century (MOXXI): effectiveness of computerized decision-making support in reducing inappropriate prescribing in primary care. CMAJ. 2003, 169 (6): 549-556.PubMedPubMedCentral Tamblyn R, Huang A, Perreault R, Jacques A, Roy D, Hanley J, McLeod P, Laprise R: The Medical Office of the 21st century (MOXXI): effectiveness of computerized decision-making support in reducing inappropriate prescribing in primary care. CMAJ. 2003, 169 (6): 549-556.PubMedPubMedCentral
27.
go back to reference Tamblyn R, Huang A, Kawasumi Y, Bartlett G, Grad R, Jacques A, Dawes M, Abrahamowicz M, Perreault R, Taylor L, Winslade N, Poissant L, Pinsonneault A: The development and evaluation of an integrated electronic prescribing and drug management system for primary care. J Am Med Inform Assoc. 2006, 13 (2): 148-159. 10.1197/jamia.M1887.CrossRefPubMedPubMedCentral Tamblyn R, Huang A, Kawasumi Y, Bartlett G, Grad R, Jacques A, Dawes M, Abrahamowicz M, Perreault R, Taylor L, Winslade N, Poissant L, Pinsonneault A: The development and evaluation of an integrated electronic prescribing and drug management system for primary care. J Am Med Inform Assoc. 2006, 13 (2): 148-159. 10.1197/jamia.M1887.CrossRefPubMedPubMedCentral
28.
go back to reference Goulet F, Jacques A, Gagnon R, Racette P, Sieber W: Assessment of family physicians' performance using patient charts: Interrater reliability and concordance with chart-stimulated recall interview. Eval Health Prof. 2007, 30 (4): 376-392. 10.1177/0163278707307924.CrossRefPubMed Goulet F, Jacques A, Gagnon R, Racette P, Sieber W: Assessment of family physicians' performance using patient charts: Interrater reliability and concordance with chart-stimulated recall interview. Eval Health Prof. 2007, 30 (4): 376-392. 10.1177/0163278707307924.CrossRefPubMed
29.
go back to reference Guerra CE, Jacobs SE, Holmes JH, Shea JA: Are physicians discussing prostate cancer screening with their patients and why or why not? A pilot study. J Gen Intern Med. 2006, 22 (7): 901-907.CrossRef Guerra CE, Jacobs SE, Holmes JH, Shea JA: Are physicians discussing prostate cancer screening with their patients and why or why not? A pilot study. J Gen Intern Med. 2006, 22 (7): 901-907.CrossRef
30.
go back to reference Mann KV: Continuing medical education: Methods for both needs assessment and performance assessment. International handbook of research in medical education: Part one. Edited by: Norman GR, van der Vleuten CPM, Newble DI. 2002, Netherlands: Kluwer Academic Publishers, 415-460.CrossRef Mann KV: Continuing medical education: Methods for both needs assessment and performance assessment. International handbook of research in medical education: Part one. Edited by: Norman GR, van der Vleuten CPM, Newble DI. 2002, Netherlands: Kluwer Academic Publishers, 415-460.CrossRef
31.
go back to reference Greving JP, Denig P, Jan van der Veen W, Beltman FW, Sturkenboom MCJM, Haaijer-Ruskamp FM: Determinants for the adoption of angiotensin II receptor blockers by general practitioners. Soc Sci Med. 2006, 63 (11): 2890-2898. 10.1016/j.socscimed.2006.07.019.CrossRefPubMed Greving JP, Denig P, Jan van der Veen W, Beltman FW, Sturkenboom MCJM, Haaijer-Ruskamp FM: Determinants for the adoption of angiotensin II receptor blockers by general practitioners. Soc Sci Med. 2006, 63 (11): 2890-2898. 10.1016/j.socscimed.2006.07.019.CrossRefPubMed
32.
go back to reference Jacoby A, Smith M, Eccles M: A qualitative study to explore influences on general practitioners' decisions to prescribe new drugs. Br J Gen Pract. 2003, 53: 120-125.PubMedPubMedCentral Jacoby A, Smith M, Eccles M: A qualitative study to explore influences on general practitioners' decisions to prescribe new drugs. Br J Gen Pract. 2003, 53: 120-125.PubMedPubMedCentral
33.
go back to reference Prosser H, Walley T: New drug uptake: qualitative comparison of high and low prescribing GPs' attitudes and approach. Fam Pract. 2003, 20 (5): 583-591. 10.1093/fampra/cmg516.CrossRefPubMed Prosser H, Walley T: New drug uptake: qualitative comparison of high and low prescribing GPs' attitudes and approach. Fam Pract. 2003, 20 (5): 583-591. 10.1093/fampra/cmg516.CrossRefPubMed
34.
go back to reference Prosser H, Almond S, Walley T: Influences on GPs' decision to prescribe new drugs--the importance of who says what. Fam Pract. 2003, 20 (1): 61-68. 10.1093/fampra/20.1.61.CrossRefPubMed Prosser H, Almond S, Walley T: Influences on GPs' decision to prescribe new drugs--the importance of who says what. Fam Pract. 2003, 20 (1): 61-68. 10.1093/fampra/20.1.61.CrossRefPubMed
35.
go back to reference Miles MB, Huberman M: Qualitative data analysis: an expanded source book. 1994, Thousand Oaks: Sage, 2 Miles MB, Huberman M: Qualitative data analysis: an expanded source book. 1994, Thousand Oaks: Sage, 2
36.
go back to reference Patton MQ: Qualitative research and evaluation methods. 2001, Thousand Oaks: Sage, 3 Patton MQ: Qualitative research and evaluation methods. 2001, Thousand Oaks: Sage, 3
37.
go back to reference Mintzberg H: An emerging strategy of direct research. Adm Sci Q. 1979, 24: 582-589. 10.2307/2392364.CrossRef Mintzberg H: An emerging strategy of direct research. Adm Sci Q. 1979, 24: 582-589. 10.2307/2392364.CrossRef
38.
go back to reference Wright JM, Musini VM: First-line drugs for hypertension. Cochrane Database of Syst Rev. 2009, 3: CD001841- Wright JM, Musini VM: First-line drugs for hypertension. Cochrane Database of Syst Rev. 2009, 3: CD001841-
39.
go back to reference Turnbull F, Blood Pressure Lowering Treatment Trialists' Collaboration: Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet. 2003, 362 (9395): 1527-1535.CrossRefPubMed Turnbull F, Blood Pressure Lowering Treatment Trialists' Collaboration: Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet. 2003, 362 (9395): 1527-1535.CrossRefPubMed
40.
go back to reference Ubel PA, Jepson C, Asch DA: Misperceptions about beta-blockers and diuretics: a national survey of primary care physicians. J Gen Intern Med. 2003, 18 (12): 977-983. 10.1111/j.1525-1497.2003.20414.x.CrossRefPubMedPubMedCentral Ubel PA, Jepson C, Asch DA: Misperceptions about beta-blockers and diuretics: a national survey of primary care physicians. J Gen Intern Med. 2003, 18 (12): 977-983. 10.1111/j.1525-1497.2003.20414.x.CrossRefPubMedPubMedCentral
41.
go back to reference Ernst ME, Moser M: Use of diuretics in patients with hypertension. N Engl J Med. 2009, 361 (22): 2153-2164. 10.1056/NEJMra0907219.CrossRefPubMed Ernst ME, Moser M: Use of diuretics in patients with hypertension. N Engl J Med. 2009, 361 (22): 2153-2164. 10.1056/NEJMra0907219.CrossRefPubMed
42.
go back to reference Moser M: Why are physicians not prescribing diuretics more frequently in the management of hypertension?. JAMA. 1998, 279 (22): 1813-1816. 10.1001/jama.279.22.1813.CrossRefPubMed Moser M: Why are physicians not prescribing diuretics more frequently in the management of hypertension?. JAMA. 1998, 279 (22): 1813-1816. 10.1001/jama.279.22.1813.CrossRefPubMed
43.
go back to reference Avorn J: Transforming trial results into practice change: the final translational hurdle: Comment on "Impact of the ALLHAT/JNC7 Dissemination Project on thiazide-type diuretic use". Arch Intern Med. 2010, 170 (10): 858-860. 10.1001/archinternmed.2010.125.CrossRefPubMed Avorn J: Transforming trial results into practice change: the final translational hurdle: Comment on "Impact of the ALLHAT/JNC7 Dissemination Project on thiazide-type diuretic use". Arch Intern Med. 2010, 170 (10): 858-860. 10.1001/archinternmed.2010.125.CrossRefPubMed
44.
go back to reference Kuehlein T, Laux G, Gutscher A, Goetz K, Szecsenyi J, Campbell S, Steinhaeuser J: Diuretics for hypertension: an inconsistency in primary care prescribing behaviour. Curr Med Res Opin. 2011, 27 (3): 497-502. 10.1185/03007995.2010.547932.CrossRefPubMed Kuehlein T, Laux G, Gutscher A, Goetz K, Szecsenyi J, Campbell S, Steinhaeuser J: Diuretics for hypertension: an inconsistency in primary care prescribing behaviour. Curr Med Res Opin. 2011, 27 (3): 497-502. 10.1185/03007995.2010.547932.CrossRefPubMed
45.
go back to reference Cushman WC, Basile J: Achieving blood pressure goals: why aren't we?. J Clin Hypertens. 2006, 8 (12): 865-872. 10.1111/j.1524-6175.2006.05789.x.CrossRef Cushman WC, Basile J: Achieving blood pressure goals: why aren't we?. J Clin Hypertens. 2006, 8 (12): 865-872. 10.1111/j.1524-6175.2006.05789.x.CrossRef
46.
go back to reference Hyman DJ, Pavlik VN: Self-reported hypertension treatment practices among primary care physicians: blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine. Arch Intern Med. 2000, 160 (15): 2281-2286. 10.1001/archinte.160.15.2281.CrossRefPubMed Hyman DJ, Pavlik VN: Self-reported hypertension treatment practices among primary care physicians: blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine. Arch Intern Med. 2000, 160 (15): 2281-2286. 10.1001/archinte.160.15.2281.CrossRefPubMed
47.
go back to reference Sica DA: Rationale for fixed-dose combinations in the treatment of hypertension: the cycle repeats. Drugs. 2002, 62 (3): 443-462. 10.2165/00003495-200262030-00003.CrossRefPubMed Sica DA: Rationale for fixed-dose combinations in the treatment of hypertension: the cycle repeats. Drugs. 2002, 62 (3): 443-462. 10.2165/00003495-200262030-00003.CrossRefPubMed
48.
go back to reference Law MR, Wald NJ, Morris JK, Jordan RE: Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ. 2003, 326 (7404): 1427-1431. 10.1136/bmj.326.7404.1427.CrossRefPubMedPubMedCentral Law MR, Wald NJ, Morris JK, Jordan RE: Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ. 2003, 326 (7404): 1427-1431. 10.1136/bmj.326.7404.1427.CrossRefPubMedPubMedCentral
Metadata
Title
What differentiates primary care physicians who predominantly prescribe diuretics for treating mild to moderate hypertension from those who do not? A comparative qualitative study
Authors
Christian M Rochefort
Julia Morlec
Robyn M Tamblyn
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Primary Care / Issue 1/2012
Electronic ISSN: 2731-4553
DOI
https://doi.org/10.1186/1471-2296-13-9

Other articles of this Issue 1/2012

BMC Primary Care 1/2012 Go to the issue